日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Gemcitabine-Ibandronate Conjugate Enables the Bone-Targeted Combination Therapy in Bone Cancer: Synthesis and Efficacy in Combination with Docetaxel

吉西他滨-伊班膦酸钠偶联物可实现骨癌的骨靶向联合治疗:合成及与多西他赛联合用药的疗效

Farrell, Kristen B; Zinnen, Shawn; Thamm, Douglas H; Karpeisky, Alexander

First-in-Human Phase I Study of MBC-11, a Novel Bone-Targeted Cytarabine-Etidronate Conjugate in Patients with Cancer-Induced Bone Disease

一项针对癌症诱发骨病患者的新型骨靶向阿糖胞苷-依替膦酸偶联物MBC-11的首次人体I期研究

Zinnen, Shawn Patrick; Karpeisky, Alexander; Von Hoff, Daniel D; Plekhova, Larisa; Alexandrov, Alexander

Bisphosphonate conjugation for bone specific drug targeting

双膦酸盐偶联用于骨特异性药物靶向治疗

Farrell, Kristen B; Karpeisky, Alexander; Thamm, Douglas H; Zinnen, Shawn

A promising approach for treatment of tumor-induced bone diseases: utilizing bisphosphonate derivatives of nucleoside antimetabolites

一种治疗肿瘤诱发骨病的有前景的方法:利用核苷抗代谢物的双膦酸盐衍生物

Reinholz, Monica M; Zinnen, Shawn P; Dueck, Amylou C; Dingli, David; Reinholz, Gregory G; Jonart, Leslie A; Kitzmann, Kathleen A; Bruzek, Amy K; Negron, Vivian; Abdalla, Abdalla K; Arendt, Bonnie K; Croatt, Anthony J; Sanchez-Perez, Luis; Sebesta, David P; Lönnberg, Harri; Yoneda, Toshiyuki; Nath, Karl A; Jelinek, Diane F; Russell, Stephen J; Ingle, James N; Spelsberg, Thomas C; Dixon, Henry B F Hal; Karpeisky, Alexander; Lingle, Wilma L

Effect of chemically modified IL-13 short interfering RNA on development of airway hyperresponsiveness in mice.

化学修饰的IL-13短干扰RNA对小鼠气道高反应性发展的影响

Lively Tricia N, Kossen Karl, Balhorn Annette, Koya Toshiyuki, Zinnen Shawn, Takeda Katsuyuki, Lucas Joseph J, Polisky Barry, Richards Ivan M, Gelfand Erwin W